Table 5 The 20 Pseudomonas aeruginosa clinical isolates and their characterization by several properties.

From: Essential oils against bacterial isolates from cystic fibrosis patients by means of antimicrobial and unsupervised machine learning approaches

ID pt

ID

SAM

date

Str

Ph

CAR

PTC

AM

QUIN

MB

CEF

COL

1St

E

L

CF

CSA

GEN

21

21P

ESP

8/8/2006

PA MDR

s

R

R

R

R

R

R

S

  

X

  

E

21

22P

ESP

1/11/2017

PA MDR

w

R

S

R

R

S

R

S

  

X

  

E

22

23P

ESP

6/24/2005

PA MDR MBL+

sm

R

S

R

R

S

R

S

 

X

   

B

22

24P

ESP

3/27/2017

PA MDR MBL+

s

R

S

R

R

S

R

S

  

X

Ca/Cl

 

B

23

25P

AT

9/3/2010

PA

sm

S

S

I

S

I

S

S

X

    

B

24

26P

TF

8/27/2008

PA

i

S

S

S

S

I

S

S

X

    

G

24

27P

AT

1/31/2017

PA

sm

S

S

S

S

S

S

S

  

X

 

X

G

25

28P

ESP

5/24/2012

PA

sm

S

S

S

S

S

S

S

X

    

U

25

29P

AT

9/13/2017

PA

m

S

S

S

S

S

S

S

  

X

  

U

9

30P

ESP

9/6/2010

PA

i

S

S

S

S

I

S

S

X

    

B

9

31P

ESP

1/11/2017

PA

m

S

S

S

R

S

S

S

  

X

 

X

B

26

32P

AT

12/5/2006

PA

sm

S

S

R

S

I

S

S

X

    

F

26

33P

AT

12/28/2016

PA

m

S

S

S

S

I

S

S

  

X

Ca

X

F

27

34P

ESP

5/11/2005

PA

i

MP I/IP R

S

S

CI S/LE R

I

S

S

X

  

Ca

 

D

27

35P

ESP

3/29/2017

PA MDR

sm

R

R

R

R

I

R

S

  

X

  

D

28

36P

TF

2/11/2008

PA

sm

S

S

S

S

I

S

S

 

X

   

A

28

37P

AT

2/22/2017

PA

m

MP S/IP R

S

R

S

S

R

S

  

X

  

A

29

38P

ESP

3/7/2006

PA MDR

s

R

R

R

R

R

R

S

  

X

  

B

29

39P

ESP

1/25/2017

PA MDR

m

R

R

R

R

I

R

S

  

X

  

B

30

40P

AT

7/1/2013

PA

i

S

S

S

S

S

S

S

X

  

Ca

X

C

  1. ID pt: patient identification;ID: strain code;SAM: Sample; Date: Date of collection; Str: Strain; Ph: Phenotype; CAR: Carbapenems; MP: Meropenem; IP: Imipenem; PTC: Piperacillin/tazobactam; AM:
  2. Aminoglycosides; QUIN: Quinolones; CI: Ciprofloxacin; LE: Levofloxacin; MB: Monobactam; CEF: Cephalosporins; COL: Colistin; 1 St: P. aeruginosa first isolate; E: P. aeruginosa early isolate; L: P. aeruginosa late isolate; CF: Fungal co-infection; CSA: S. aureus co-infection; Gen: pts genotype; BP: Biofilm Producer; Esp:sputum; AT: hypopharyngeal suction; TF: throat swabs; PA: P. aeruginosa; PA MDR: P. aeruginosa multi-drug resistant; PA MBL+: P. aeruginosa Metallo-Beta-Lactamases producing; s: small colony phenotype; w- wrinkled colony surface; m: mucoid colony; i: irregular colony edges; sm: smooth phenotype; R: Resistant; S: Susceptible; I: Intermediate; CA: Candida albicans; CL: Candida lusitaniae; X: denotes positive for the feature. See Table 6 showing the correlation between letter code, CFTR gene mutation of the patient and bacterial strain isolated from the same patient.
Back to article page